Dr. Charles Connor, M.D.
What this data tells you about Dr. Connor
Dr. Charles Connor is a medical oncology in Plano, TX, with 19 years in practice. Based on federal Medicare data, Dr. Connor performed 59,012 Medicare services across 2,612 unique beneficiaries.
Between the years covered by Open Payments, Dr. Connor received a total of $1,694 from 24 pharmaceutical and/or device companies across 47 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Connor is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) | 23,400 | $0 | $2 |
| Darbepoetin injection (Aranesp) for anemia | 12,750 | $2 | $20 |
| Pembrolizumab injection (Keytruda) | 4,400 | $43 | $136 |
| Contrast dye for imaging (iodine-based) | 4,001 | $0 | $3 |
| Immune globulin infusion (Octagam) | 2,590 | $34 | $233 |
| Paclitaxel chemotherapy injection | 2,268 | $0 | $8 |
| Denosumab injection (Prolia/Xgeva) | 1,620 | $18 | $65 |
| Dexamethasone injection (steroid) | 1,414 | $0 | $1 |
| Injection, granisetron hydrochloride, 100 mcg | 840 | $0 | $24 |
| Blood draw (venipuncture) | 689 | $8 | $20 |
| Complete blood count (CBC) with differential | 670 | $8 | $36 |
| Comprehensive metabolic blood panel | 542 | $10 | $64 |
| Injection of additional new drug or substance into vein | 395 | $12 | $108 |
| Office visit, established patient (20-29 min) | 388 | $62 | $250 |
| Anti-nausea injection (Aloxi/palonosetron) | 270 | $1 | $114 |
| Administration of chemotherapy into vein, 1 hour or less | 220 | $97 | $707 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 189 | $47 | $313 |
| Ferritin level test (iron stores) | 178 | $13 | $60 |
| Drug injection, under skin or into muscle | 139 | $10 | $96 |
| Injection, fluorouracil, 500 mg | 115 | $2 | $13 |
| Iron level test | 114 | $6 | $27 |
| Iron binding capacity test | 114 | $9 | $35 |
| Office visit, established patient (30-39 min) | 103 | $89 | $368 |
| Injection, zoledronic acid, 1 mg | 101 | $7 | $431 |
| Injection, diphenhydramine hcl, up to 50 mg | 98 | $1 | $7 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 92 | $54 | $211 |
| Injection, carboplatin, 50 mg | 92 | $2 | $300 |
| Infusion, normal saline solution , 1000 cc | 79 | $2 | $19 |
| Lactate dehydrogenase (enzyme) level | 78 | $6 | $31 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 76 | $16 | $100 |
| Reticulated (young) platelet measurement | 75 | $35 | $143 |
| Unclassified drugs | 74 | $1 | $8 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 71 | $22 | $157 |
| Administration of chemotherapy into vein, each additional hour | 66 | $21 | $161 |
| Administration of additional new drug or substance into vein, 1 hour or less | 62 | $49 | $344 |
| Infusion into a vein for hydration, each additional hour | 50 | $10 | $75 |
| Microscopic examination for white blood cells with manual cell count | 49 | $4 | $22 |
| Complete blood count (CBC), automated | 49 | $6 | $34 |
| Ct scan of chest with contrast | 44 | $46 | $821 |
| New patient office visit (30-44 min) | 40 | $78 | $372 |
| CT scan of abdomen and pelvis with contrast | 39 | $168 | $1,067 |
| Drawing of blood for a medical problem | 35 | $63 | $264 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev | 32 | $177 | $700 |
| CT scan of chest, without contrast | 25 | $35 | $686 |
| Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 25 | $272 | $2,762 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 24 | $15 | $94 |
| Red blood count, automated test | 21 | $4 | $23 |
| Infusion into a vein for hydration, 31-60 minutes | 21 | $25 | $256 |
| Hospital follow-up visit, moderate complexity | 21 | $61 | $247 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev | 21 | $178 | $700 |
| Ct scan of abdomen and pelvis without contrast | 20 | $71 | $560 |
| Office visit, established patient (10-19 min) | 20 | $33 | $150 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 20 | $339 | $1,722 |
| Injection of drug or substance into vein | 19 | $28 | $247 |
| Irrigation of implanted venous access drug delivery device | 18 | $17 | $114 |
| Administration of additional new drug or substance into vein using push technique | 17 | $42 | $289 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 16 | $91 | $657 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 13 | $1,115 | $4,802 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (93%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Connor is a mixed practice specialist, with above-average Medicare volume (top 17% in TX), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Connor experienced with iron sucrose injection (venofer)?
Does Dr. Connor receive payments from pharmaceutical companies?
How do Dr. Connor's costs compare to other medical oncologys in Plano?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology